Menu

Human Species May Be Much Older Than Previously Thought

From DNA evidence, researchers estimate the split from other species took place between 260,000 and 350,000 years ago.

Sep 29, 2017
Shawna Williams

ISTOCK, MICROGENA comparison of the genomes of Stone Age hunter-gatherer bones found in South Africa with those of other populations suggests Homo sapiens arose much earlier than the commonly accepted estimate of 200,000 years ago, researchers reported yesterday (September 28) in Science.

The team analyzed DNA of seven skeletons from the KwaZulu-Natal province of South Africa. Three were hunter-gatherers who lived during the Stone Age, about 2,000 years ago, and four were Iron Age farmers who lived between 300 and 500 years ago. The researchers compared their genomes with those of other ancient and modern people to reconstruct when different groups split off from one another. Their reasoning was that the splits must have occurred after the human species arose, Mattias Jakobsson of Uppsala University in Sweden tells the Associated Press. Based on those estimates, his group reports that Homo sapiens likely diverged from another related species between 260,000 and 350,000 years ago.

See “Scientists Uncover Oldest Homo Sapiens Fossils to Date

“The reconstruction of deep human history in Africa is becoming increasingly robust when the dating of fossils, such as those from Morocco, the Stone Age archaeological record and human DNA come together to highlight interesting periods in our evolutionary past,” another of the study’s authors, Marlize Lombard of the University of Johannesburg, tells Reuters.

Demographic model of African history and estimated divergences. Vertical colored lines represent migration, with down-pointing triangles representing admixture into another group. Southern African hunter-gatherers are shown by red symbols and Iron Age farmers in green symbols. C. SCHLEBUSCH ET AL. SCIENCE (2017)Todd Disotell, an anthropologist at New York University, tells the Associated Press he’s sceptical of assumptions used in the study’s calculations, and thinks the evidence is still compelling that the split between species that produced Homo sapiens occurred closer to 200,000 years ago.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.